Compare Nokia Corp (NOK) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Sana Biotechnology Inc — how do they compare? Nokia Corp trades at $10.94 (market cap $56.70B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Nokia Corp is far larger — about 64.9× Sana Biotechnology Inc's market cap, and Nokia Corp pays a 1.63% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| NOK | SANA | |
|---|---|---|
Market Cap | $56.70B | $873.84M |
Sector | Technology | Health |
52-Week High | $16.83 | $5.92 |
52-Week Low | $4.05 | $2.68 |
Enterprise Value | $53.51B | $848.03M |
Dividend Yield | 1.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
